Patients Diagnosed With Scleroderma: Physical Performance and Functionality

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7+
SponsorHacettepe University

About this trial

Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. In light of all this literature, the aim was to evaluate the biopsychosocial characteristics of both pediatric and adult scleroderma patients and to examine their physical performance and functionality.

Additionally, this study aims to identify effective tests that can be used in future research to assess physical performance and functionality in individuals diagnosed with scleroderma.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Cases diagnosed with scleroderma,

Cases aged 7-18 years will be included.

Disqualifiers

Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies

Cases that are not willing to participate in the study will be excluded.

Having participated in a regular exercise program for the past 3 months

Individuals who are not willing to participate in the study

Trial population

The study population will consist of individuals who come to the university hospital for routine controls.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Questionnaire and functionality application for child and adult scleroderma patients

    Other intervention

    Scales and functionality tests will be applied to cases diagnosed with scleroderma

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Cases diagnosed with scleroderma1 intervention

Trial outcomes

Primary outcomes

1

6-Minute Walk Test

Participants are asked to walk as quickly as they can along a 30-meter corridor. The total distance will be measured in meters. Fatigue, pain and dyspnea will be monitored using the Modified Borg Scale.

Time frame
Two weeks
2

Timed Up and Go Test

The time it takes for a person to get up from a chair with back support, walk 3 meters at a normal pace, and return to the chair is measured in seconds to evaluate lower extremity balance. The test will be performed 3 times.

Time frame
Two weeks
3

10-Step Stair Climbing Test

To assess the subject's lower extremity strength and dynamic balance, the time taken to quickly climb and descend a staircase with 10 steps, each measuring 16-20 cm high and equipped with a handrail, is recorded in seconds. The test is repeated three times, and the times are recorded.

Time frame
Two weeks
4

10-meter walk test

The individual is on a 10-meter path. The assessment is performed in three repetitions and recorded in seconds.

Time frame
Two weeks

Secondary outcomes

1

Childhood Health Assessment Questionnaire (CHAQ)

It assesses the functional abilities of children diagnosed with rheumatic diseases in their daily living activities. It consists of eight subscales (dressing and personal care, standing up, eating, walking, body care, reaching, grasping, activities) (0-3) and also assesses pain and general well-being using a visual analog scale (0-100). A high score indicates low functionality.

Time frame
Two weeks
2

Juvenile Arthritis Quality of Life Questionnaire (JAQQ)

It consists of 74 items covering various health domains, including physical functioning, emotional well-being, and general symptoms. The items are divided into four dimensions related to the child's quality of life: gross motor function (GMF), fine motor function (FMF), psychosocial function (PF), and systemic or general symptoms (SGS). Each domain is scored on a Likert-type scale from 1 to 7; higher scores indicate poorer health-related quality of life. There is also a "not applicable to me" option for the items. The scale also includes a pain measurement (10 cm Visual Analog Scale (VAS)) to assess pain, but this score is not included in the total score.

Time frame
Two weeks
3

Juvenile Arthritis Biopsychosocial Scale-JAB-Q-Patient

It is a patient/parent-centered measurement method that helps assess the patient's biopsychosocial aspects, such as disease activity, posture, functional and psychosocial status, fatigue, and school performance. The results from the questions are used to assess the functional status of children, while their psychosocial status is recorded based on their answers to 21 questions (ranging from 0 to 358). A high score indicates a poor psychosocial status.

Time frame
Two weeks
4

Juvenile Arthritis Biopsychosocial Scale-JAB-Q-Family

JAB-Q is a multidimensional questionnaire and a parent (family) form. Developed in Turkish by Ünal and colleagues, the questionnaire is completed by one of the child's parents. The family form evaluates the parents' biopsychosocial status from their own perspective and provides scores ranging from 0 to 102. Higher scores indicate a worse biopsychosocial status.

Time frame
Two weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.